You are here

Lenfanjioma Sirkumskriptumlu Bir Olgu Sunumu

Lymphangioma Circumscriptum: A Case Report

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Lymphangioma circumscriptum (LC) is a rare vascular malformation affecting the skin and the subcutaneous tissues. It is characterized by the appearance of clusters of thin-walled vesicles. They usually filled with colorless fluid and occasionally with blood. Lesions may resemble frog spawn. The disease can be primary and secondary, also can be classified into classic and localized forms. The various modalities that have been used are surgical excision, incision and drainage, injection of sclerosing agents, electrocautery, cryotherapy, CO2 laser and radiotherapy. In this report, a 14 year-old girl diagnosed as LC was presented because the disease is infrequent.
Abstract (Original Language): 
Lenfanjioma sirkumskriptum (LS), deri ve subkutan dokuları etkileyen nadir bir vasküler malformasyondur. Genellikle renksiz sıvı, bazen kan ile dolu, ince duvarlı vezikül kümeleri ile karakterizedir. Lezyonlar kurbağa yumurtasını andıran görünüme sahiptir. Hastalık klasik ve lokalize olarak ayrılırken, primer veya sekonder olarak gelişebilir. Tedavide; cerrahi eksizyon, insizyon ve drenaj, sklerozan ajanların enjeksiyonu, elektrokoter, kriyoterapi, CO2 lazer ve radyoterapi uygulanır. Burada LS tanısı almış on dört yaşında kız hasta, hastalığın nadir görülmesi sebebiyle sunuldu.
129-131

REFERENCES

References: 

1. Niti K, Manish P. Microcystic lymphatic malformation
(lymphangioma circumscriptum) treated using a minimally
invasive technique of radiofrequency ablation and sclerotherapy.
Dermatol Surg 2010; 36: 1711-7.
Lenfanjioma Sirkumskriptumlu Bir Olgu Sunumu
131
2. Omprakash Hm, Rajendran Sc. Lymphangioma circumscriptum
(microcystic lymphatic malformation): palliative coagulation
using radiofrequency current. J Cutan Aesthet Surg 2008; 1: 85-8.
3. Coşkun BK, Saral Y, Ataseven A. Dört kez nükseden
lenfanjioma sircumscriptum olgusu. Fırat Tıp Dergisi 2004; 9: 91-
2.
4. Dikmen Y, Coşan Terek M, Akman L, Solmaz U, Zekioğlu O,
Akalin T. Congenital vulvar lymphangioma circumscriptum. Int J
Clin Oncol 2008; 13: 458-60.
5. Bond J, Basheer MH, Gordon D. Lymphangioma
circumscriptum: pitfalls and problems in definitive management.
Dermatol Surg 2008; 34: 271-5.
6. Itakura E, Yamamoto H, Oda Y, Furue M, Tsuneyoshi M.
Virchows Arch. VEGF-C and VEGFR-3 in a series of
lymphangiomas: is superficial lymphangioma a true
lymphangioma? Virchows Arch 2009; 454: 317-25.
7. Thissen CA, Sommer A. Treatment of lymphangioma
circumscriptum with the intense pulsed light system. Int J
Dermatol 2007; 46 (Suppl 3): 16-8.
8. Bikowski JB, Dumont AM. Lymphangioma circumscriptum:
treatment with hypertonic saline sclerotherapy. J Am Acad
Dermatol 2005; 53: 442-4.
9. Huilgol SC, Neill S, Barlow RJ. CO(2) laser therapy of vulval
lymphangiectasia and lymphangioma circumscriptum. Dermatol
Surg 2002; 28: 575-7.
10. Lai CH, Hanson SG, Mallory SB. Lymphangioma
circumscriptum treated with pulsed dye laser. Pediatr Dermatol
2001; 18: 509-10.

Thank you for copying data from http://www.arastirmax.com